Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Urinary Oxalate Excretion & Risk of CKD Progression

JAMA Intern Med; ePub 2019 Mar 4; Waikar, et al

In individuals with chronic kidney disease (CKD) stages 2 to 4, higher 24-hour urinary oxalate excretion may be a risk factor for CKD progression and end-stage renal disease (ESRD), a new study found. Researchers assessed 3,123 individuals with CKD stages 2 to 4 CKD to determine whether urinary oxalate excretion is a risk factor for more rapid progression of CKD toward kidney failure. The primary outcomes were a 50% decline in estimated glomerular filtration rate (eGFR) and ESRD. They found:

  • During 22,318 person-years of follow-up, 752 individuals reached ESRD, and 940 reached the composite end point of ESRD or 50% decline in eGFR (CKD progression).
  • Higher oxalate excretion was independently associated with greater risks of both CKD progression and ESRD.
  • Higher urinary excretion of oxalate was associated with a 37% greater adjusted risk of future end-stage kidney disease.

Citation:

Waikar SS, Srivastava A, Palsson R, et al. Association of urinary oxalate excretion with the risk of chronic kidney disease progression. [Published online ahead of print March 4, 2019]. JAMA Intern Med. doi:10.1001/jamainternmed.2018.7980.

This Week's Must Reads

Patient-Centered Intervention for Prostate Ca Care, J Clin Oncol; ePub 2019 Mar 12; Jayadevappa, et al

Subsequent Cancer Risk in Prostate Cancer, Lancet Oncol; ePub 2019 Mar 15; Mohamad, et al

Accuracy of 68Ga-PSMA-11 PET in Prostate Cancer, JAMA Oncol; ePub 2019 Mar 28; Fendler, et al

Low Muscle Mass in Patients with Prostate Cancer, J Urol; ePub 2019 Mar 27; Pak, Park, et al

Steroid Hormones & Progression of Prostate Cancer, Cancer Epidemiol Biomarkers Prev; ePub 2019 Mar 27; Lévesque, et al

Must Reads in Nephrology

Urinary Oxalate Excretion & Risk of CKD Progression, JAMA Intern Med; ePub 2019 Mar 4; Waikar, et al

NSAID Exposure Linked by Incident Kidney Problems, JAMA Netw Open; 2019 Feb 15; Nelson, et al

Adiposity and Risk of Decline in GFR, BMJ; ePub 2019 Jan 10; Chang, Grams, et al

Predictors of Symptomatic Kidney Stone Recurrence, Mayo Clin Proc; ePub 2018 Dec 4; Vaughan, et al

Kidney Damage Biomarkers & Incident CKD in BP Reduction, Ann Intern Med; ePub 2018 Oct 23; Zhang, et al